FDA sends warning letter to Novo Nordisk over failure to report deaths, adverse side effects of GLP-1s

The U.S. Food and Drug Administration (FDA) has issued a warning to Novo Nordisk over its alleged failure to report adverse ...

FDA sends warning letter to maker of Ozempic, Wegovy over unreported potential GLP-1 side effects

The FDA sent a warning letter this month to Novo Nordisk, alleging the drugmaker failed to report, in a timely manner, potential side effects in patients who took its popular medications containing ...
102.5 The Bone Tampa on MSN

FDA sends warning letter to Novo Nordisk over Ozempic, Wegovy side effects

The Food and Drug Administration sent a warning letter to the makers of Ozempic and Wegovy for not reporting potential side effects of the drugs.
Pharmaceutical Commerce

FDA Issues 30 Warning Letters to Telehealth Firms Over Misleading Compounded GLP-1 Marketing

Thirty telehealth firms received warning letters for illegal promotion of compounded semaglutide/tirzepatide, reflecting an expanded enforcement tempo that now surpasses the prior decade’s letter ...
FiercePharma

FDA ramps up crackdown on GLP-1 drug compounding with fresh batch of 30 warning letters

The FDA is taking no prisoners as it continues its efforts to combat widespread GLP-1 drug compounding. In its latest offensive, the agency has unleashed a fresh set of 30 warning letters targeting ...